Literature DB >> 10530980

The prevalence of strabismus in congenital nystagmus: the influence of anterior visual pathway disease.

M C Brodsky1, K J Fray.   

Abstract

PURPOSE: To determine the influence of underlying visual system disorders on the risk of developing strabismus in children with congenital nystagmus.
METHODS: We retrospectively reviewed 82 cases of congenital nystagmus from a pediatric ophthalmology referral practice.
RESULTS: Strabismus was found in 50% of children with congenital nystagmus. The prevalence of strabismus was 82% in children with bilateral optic nerve hypoplasia, 53% in patients with albinism, 36% in children with congenital retinal dystrophies, and 17% in children with idiopathic congenital nystagmus.
CONCLUSION: The risk that a child with congenital nystagmus will have strabismus develop can be predicted from the nature of the underlying visual disorder.

Entities:  

Mesh:

Year:  1997        PMID: 10530980     DOI: 10.1016/s1091-8531(97)90018-5

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  4 in total

1.  Design and efficacy of surgery for horizontal idiopathic nystagmus with abnormal head posture and strabismus.

Authors:  Ping Wang; Liping Lou; Lin Song
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-10-25

Review 2.  Nystagmus.

Authors:  J S Stahl; R J Leigh
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

3.  The effect of strabismus on object detection in the ring scotoma of a monocular bioptic telescope.

Authors:  Amy L Doherty; Alex R Bowers; Gang Luo; Eli Peli
Journal:  Ophthalmic Physiol Opt       Date:  2013-05-03       Impact factor: 3.117

Review 4.  Management of nystagmus in children: a review of the literature and current practice in UK specialist services.

Authors:  J E Self; M J Dunn; J T Erichsen; I Gottlob; H J Griffiths; C Harris; H Lee; J Owen; J Sanders; F Shawkat; M Theodorou; J P Whittle
Journal:  Eye (Lond)       Date:  2020-01-09       Impact factor: 3.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.